Phytochemical-loaded liposomes for anticancer therapy: an updated review
VP Chavda, D Vihol, B Mehta, D Shah, M Patel… - …, 2022 - Taylor & Francis
The major obstacles observed in current chemotherapy are severe adverse effects, narrow
therapeutic indexes and multidrug resistance. Anticancer phytochemicals are extracted and …
therapeutic indexes and multidrug resistance. Anticancer phytochemicals are extracted and …
Recent advances in doxorubicin formulation to enhance pharmacokinetics and tumor targeting
J Lee, MK Choi, IS Song - Pharmaceuticals, 2023 - mdpi.com
Doxorubicin (DOX), a widely used drug in cancer chemotherapy, induces cell death via
multiple intracellular interactions, generating reactive oxygen species and DNA-adducted …
multiple intracellular interactions, generating reactive oxygen species and DNA-adducted …
Lipid nanocarrier-based drug delivery systems: therapeutic advances in the treatment of lung cancer
Although various treatments are currently being developed, lung cancer still has a very high
mortality rate. Moreover, while various strategies for the diagnosis and treatment of lung …
mortality rate. Moreover, while various strategies for the diagnosis and treatment of lung …
Hepcidin upregulation in lung cancer: a potential therapeutic target associated with immune infiltration
Y Fan, B Liu, F Chen, Z Song, B Han, Y Meng… - Frontiers in …, 2021 - frontiersin.org
Lung cancer has the highest death rate among cancers globally. Hepcidin is a fascinating
regulator of iron metabolism; however, the prognostic value of hepcidin and its correlation …
regulator of iron metabolism; however, the prognostic value of hepcidin and its correlation …
Comprehensive insights into oral squamous cell carcinoma: diagnosis, pathogenesis, and therapeutic advances
D Jagadeesan, KV Sathasivam, NK Fuloria… - … -Research and Practice, 2024 - Elsevier
Oral squamous cell carcinoma (OSCC) is considered the most common type of head and
neck squamous cell carcinoma (HNSCC) as it holds 90% of HNSCC cases that arise from …
neck squamous cell carcinoma (HNSCC) as it holds 90% of HNSCC cases that arise from …
Nano-based targeted drug delivery for lung cancer: therapeutic avenues and challenges
Most anticancer drugs often fail in clinical trials due to poor solubility, poor bioavailability,
lack of targeted delivery and several off-target effects. Polymeric nanoparticles such as poly …
lack of targeted delivery and several off-target effects. Polymeric nanoparticles such as poly …
The nanosystems involved in treating lung cancer
Even though there are various types of cancer, this pathology as a whole is considered the
principal cause of death worldwide. Lung cancer is known as a heterogeneous condition …
principal cause of death worldwide. Lung cancer is known as a heterogeneous condition …
Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer
The multi-dimensional challenge of drug resistance is one of the pivotal hindrances for
cancer chemotherapy. A reductive approach to define and distinguish the main aspects of …
cancer chemotherapy. A reductive approach to define and distinguish the main aspects of …
Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis
LÁ Ibarra-Sánchez, A Gámez-Méndez… - Journal of Drug Delivery …, 2022 - Elsevier
Respiratory diseases are leading causes of death and disability in develo** and
developed countries. The burden of acute and chronic respiratory diseases has been rising …
developed countries. The burden of acute and chronic respiratory diseases has been rising …
Clinical trials for oral, inhaled and intravenous drug delivery system for lung cancer and emerging nanomedicine-based approaches
Lung cancer is one of the most common malignant tumors worldwide and is characterized
by high morbidity and mortality rates and a poor prognosis. It is the leading cause of cancer …
by high morbidity and mortality rates and a poor prognosis. It is the leading cause of cancer …